- Home
- CWST vs ROIV Comparison
CWST vs ROIV Comparison
Compare CWST & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CWST | ROIV |
|---|---|---|
| Founded | 1975 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 14.1B |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | CWST | ROIV |
|---|---|---|
| Price | $101.08 | $22.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 8 |
| Target Price | ★ $118.67 | $24.31 |
| AVG Volume (30 Days) | 1.5M | ★ 8.2M |
| Earning Date | 02-11-2026 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 102.54 | N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $1,795,272,000.00 | $20,329,000.00 |
| Revenue This Year | $20.40 | N/A |
| Revenue Next Year | $7.63 | $741.42 |
| P/E Ratio | $420.83 | ★ N/A |
| Revenue Growth | ★ 20.54 | N/A |
| 52 Week Low | $82.22 | $8.73 |
| 52 Week High | $121.24 | $23.47 |
Technical Indicators
Market Signals| Indicator | CWST | ROIV |
|---|---|---|
| Relative Strength Index (RSI) | 65.43 | 58.09 |
| Support Level | $98.14 | $21.60 |
| Resistance Level | $101.75 | $22.72 |
| Average True Range (ATR) | 2.27 | 0.82 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 83.93 | 61.77 |
Price Performance
Historical ComparisonAbout CWST Casella Waste Systems Inc.
Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.